These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32964159)

  • 1. Diclofenac-proline nano-co-crystal development, characterization, in vitro dissolution and diffusion study.
    Nugrahani I; Auli WN
    Heliyon; 2020 Sep; 6(9):e04864. PubMed ID: 32964159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets.
    Arafa MF; El-Gizawy SA; Osman MA; El Maghraby GM
    Pharm Dev Technol; 2018 Jun; 23(5):454-463. PubMed ID: 27681386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composing Novel Diclofenac Potassium and l-Proline Salt Cocrystal as a Strategy to Increase Solubility and Dissolution.
    Nugrahani I; Komara SW; Horikawa A; Uekusa H
    J Pharm Sci; 2020 Nov; 109(11):3423-3438. PubMed ID: 32777219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salt Cocrystal of Diclofenac Sodium-L-Proline: Structural, Pseudopolymorphism, and Pharmaceutics Performance Study.
    Nugrahani I; Kumalasari RA; Auli WN; Horikawa A; Uekusa H
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32708314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of co-crystal formation with caffeine and citric acid via liquid-assisted grinding analyzed using the distinct element method.
    Shimono K; Kadota K; Tozuka Y; Shimosaka A; Shirakawa Y; Hidaka J
    Eur J Pharm Sci; 2015 Aug; 76():217-24. PubMed ID: 25998562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
    Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
    J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets.
    Arafa MF; El-Gizawy SA; Osman MA; El Maghraby GM
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1225-33. PubMed ID: 26555927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diclofenac-beta-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies.
    Manca ML; Zaru M; Ennas G; Valenti D; Sinico C; Loy G; Fadda AM
    AAPS PharmSciTech; 2005 Oct; 6(3):E464-72. PubMed ID: 16354006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the wetting and dissolution of ibuprofen using solventless co-milling.
    Varghese S; Ghoroi C
    Int J Pharm; 2017 Nov; 533(1):145-155. PubMed ID: 28951348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on Enhanced Dissolution of Azilsartan-Loaded Solid Dispersion, Prepared by Combining Wet Milling and Spray-Drying Technologies.
    Lu T; Sun Y; Ding D; Zhang Q; Fan R; He Z; Wang J
    AAPS PharmSciTech; 2017 Feb; 18(2):473-480. PubMed ID: 27116201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zwitterionic cocrystal of diclofenac and l-proline: Structure determination, solubility, kinetics of cocrystallization, and stability study.
    Nugrahani I; Utami D; Ibrahim S; Nugraha YP; Uekusa H
    Eur J Pharm Sci; 2018 May; 117():168-176. PubMed ID: 29475066
    [No Abstract]   [Full Text] [Related]  

  • 12. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
    Freag MS; Elnaggar YS; Abdallah OY
    Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel nanosized formulations of two diclofenac acid polymorphs to improve topical bioavailability.
    Pireddu R; Sinico C; Ennas G; Marongiu F; Muzzalupo R; Lai F; Fadda AM
    Eur J Pharm Sci; 2015 Sep; 77():208-15. PubMed ID: 26116276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
    Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
    Pharm Res; 2008 Mar; 25(3):563-77. PubMed ID: 17828444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide.
    El-Gizawy SA; Osman MA; Arafa MF; El Maghraby GM
    Int J Pharm; 2015 Jan; 478(2):773-8. PubMed ID: 25529436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bottom-Up and Top-Down Approaches to Explore Sodium Dodecyl Sulfate and Soluplus on the Crystallization Inhibition and Dissolution of Felodipine Extrudates.
    Chen J; Chen Y; Huang W; Wang H; Du Y; Xiong S
    J Pharm Sci; 2018 Sep; 107(9):2366-2376. PubMed ID: 29738699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of L-Lysine Amino Acid-Based Co-Crystal of Telmisartan Using Crystal Engineering Approach to Improve Solubility, Dissolution, and Micrometric Properties.
    Bhatt NK; Haneef J; Vyas M; Khatik GL
    Curr Drug Deliv; 2021; 18(5):596-606. PubMed ID: 32881671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Characterization of Co-Crystals of Chlordiazepoxide with
    Garbacz P; Paukszta D; Sikorski A; Wesolowski M
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32659986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and Solid State Characterization of Nicotinamide-based Co-crystals of Fenofibrate.
    Shewale S; Shete AS; Doijad RC; Kadam SS; Patil VA; Yadav AV
    Indian J Pharm Sci; 2015; 77(3):328-34. PubMed ID: 26180279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties.
    Bukovec P; Benkic P; Smrkolj M; Vrecer F
    Pharmazie; 2016 May; 71(5):263-8. PubMed ID: 27348970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.